EXHIBIT 10.54 UNIVERSITY RESEARCH PARK GROUND LEASE This Lease is made, executed and delivered as of the 1st day of October, 1998, by and between University Research Park, Inc., a Wisconsin nonprofit corporation with its principal place of business...Invitrogen Corp • May 12th, 2003 • Biological products, (no disgnostic substances) • Wisconsin
MORPHAGEN, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • July 10th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
by and amongRegistration Rights Agreement • March 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
SERVICE AGREEMENTService Agreement • March 21st, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.13 INDEMNIFICATION AGREEMENT This Indemnification Agreement made and entered into this 14 day of Sept., 2000 ("Agreement"), by and between Invitrogen Corporation, a Delaware corporation (together with any successor or successors and...Indemnification Agreement • March 21st, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 2.1 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 11th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
PURCHASE AGREEMENT THIS AGREEMENT is made and is effective this 1st day of, JULY 1994, (the "Effective Date") by and between CAYLA having its technical offices located at Centre Commercial de Gros, Avenue de Larrieu, 31094 Toulouse Cedex, France and...Purchase Agreement • December 10th, 1998 • Invitrogen Corp
UNDERWRITING AGREEMENTUnderwriting Agreement • October 22nd, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
INDENTURE DATED AS OF DECEMBER 11, 2001Invitrogen Corp • March 11th, 2002 • Biological products, (no disgnostic substances) • New York
ANDRights Agreement • March 30th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
3,500,000 SharesUnderwriting Agreement • January 28th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
PURCHASE AGREEMENTPurchase Agreement • March 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances)
ARTICLE 1 TERM OF AGREEMENTEmployment Agreement • September 14th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
LICENSE AGREEMENT (SK# 2302)License Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
Exhibit 10.4 CHANGE-IN-CONTROL AGREEMENT AGREEMENT by and between LIFE TECHNOLOGIES, INC., a Delaware Corporation (the "Company"), and C. Eric Winzer (the "Executive"), dated as of the 13th day of February 1997. The Board of Directors of the Company...Control Agreement • November 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
500,000,000 2 1/4% CONVERTIBLE SUBORDINATED NOTES DUE 2006 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 11th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • July 10th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.47 RECORDING REQUESTED BY: AND WHEN RECORDED MAIL TO: Gray Cary Ware & Freidenrich LLP Att'n: Joseph A. Delaney, Esq. 401 B Street, Suite 2000 San Diego, CA 92101-4240 ----------------------------------------------------------...Invitrogen Corp • August 13th, 2002 • Biological products, (no disgnostic substances)
by and amongPatent License Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances)
Exhibit 10.2 CONTRACT OF SALE THIS CONTRACT OF SALE ("THIS CONTRACT") is made and entered into as of March 7, 2001 (the "CONTRACT DATE") by and between INVITROGEN CORPORATION, a Delaware corporation ("SELLER"), and HUMAN GENOME SCIENCES, INC., a...Contract of Sale • May 15th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • Maryland
UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 1998 • Invitrogen Corp • New York
PURCHASE AGREEMENT THIS AGREEMENT is made and is effective this 1st day of, JULY 1994, (the "Effective Date") by and between CAYLA having its technical offices located at Centre Commercial de Gros, Avenue de Larrieu, 31094 Toulouse Cedex, France and...Purchase Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances)
CREDIT AGREEMENT dated as of February 14, 2012 among LIFE TECHNOLOGIES CORPORATION, as U.S. Borrower, APPLIED BIOSYSTEMS FINANCE B.V., LIFE TECHNOLOGIES EUROPE B.V., and LIFE TECHNOLOGIES FINANCE LIMITED, as Foreign Borrowers, THE LENDERS FROM TIME TO...Credit Agreement • February 14th, 2012 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York
Credit Agreement (“Agreement”) dated as of February 14, 2012 among LIFE TECHNOLOGIES CORPORATION, a Delaware corporation (the “U.S. Borrower”), APPLIED BIOSYSTEMS FINANCE B.V., a company organized under the laws of the Netherlands (“ABFBV”), LIFE TECHNOLOGIES EUROPE B.V., a company organized under the laws of the Netherlands (“LTEBV”), LIFE TECHNOLOGIES FINANCE LIMITED, a company organized under the laws of Scotland (“LTFLTD”), each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”) and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.
RECITALSAgreement • July 9th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • Wisconsin
CREDIT AGREEMENT dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, THE LENDERS FROM TIME TO TIME PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY...Credit Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York
Credit Agreement (“Agreement”) dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY SENIOR FUNDING, INC. as Co-Syndication Agents, and DnB NOR BANK ASA and THE BANK OF NOVA SCOTIA, as Co-Documentation Agents.
INDENTUREInvitrogen Corp • March 14th, 2000 • Biological products, (no disgnostic substances) • New York
Exhibit 10.3 CHANGE-IN-CONTROL AGREEMENT AGREEMENT by and between LIFE TECHNOLOGIES, INC., a Delaware Corporation (the "Company"), and J. Stark Thompson, Ph.D. (the "Executive"), dated as of the 13th day of February 1997. The Board of Directors of the...Change- • November 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • March 2nd, 2007 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and [Name] (the “Executive”), dated as of the th Day of , 20 .
LIFE TECHNOLOGIES CORPORATION, as the Company and U.S. Bank National Association, as Trustee Indenture Dated as of February 19, 2010 Senior Debt SecuritiesLife Technologies Corp • February 19th, 2010 • Biological products, (no disgnostic substances) • New York
EXHIBIT 99.2 INVITROGEN CORPORATION RESTRICTED STOCK AGREEMENT Invitrogen Corporation (the "COMPANY") has granted to Gregory T. Lucier (the "PARTICIPANT") an Award consisting of Shares subject to the terms and conditions set forth in this Restricted...Restricted Stock Agreement • May 30th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
Exhibit 10.2 CHANGE-IN-CONTROL AGREEMENT AGREEMENT by and between INVITROGEN CORPORATION, a Delaware Corporation (the "Company"), and James R. Glynn (the "Executive"), dated as of the 1st day of June 2001. The Board of Directors of the Company (the...In-Control Agreement • August 9th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
AMENDMENT TO CHANGE IN CONTROL AGREEMENTChange in Control Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances)
THIS AMENDMENT to the CHANGE-IN-CONTROL AGREEMENT (the “Amendment”) is made and entered into as of November 21, 2008, by and between INVITROGEN CORPORATION, a Delaware corporation (the “Company”) and David F. Hoffmeister (“Executive”).
ContractRegistration Rights Agreement • June 24th, 2005 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 20, 2005 by and among Invitrogen Corporation, a Delaware corporation (the “Company”), and UBS Securities LLC (“UBS”) and Banc of America Securities LLC (“BoA”) (each an “Initial Purchaser” and together, the “Initial Purchasers”). The Company proposes to issue and sell to the Initial Purchasers (the “Initial Placement”) $325,000,000 in aggregate principal amount of its 3.25% Convertible Senior Notes due 2025 (the “Firm Convertible Notes”). The Company also proposes to issue and sell to the Initial Purchasers not more than $25,000,000 in aggregate principal amount of its 3.25% Convertible Senior Notes due 2025 (the “Additional Convertible Notes” and, together with the Firm Convertible Notes, the “Notes”) to cover over-allotments. As an inducement to the Initial Purchasers to enter into the purchase agreement, dated as of June 14, 2005 (the “Purchase Agreement”), and in satisfaction of a condition to
EXHIBIT 10.38 SETTLEMENT AND RETENTION AGREEMENT This Settlement and Retention Agreement (the "Agreement") is entered into by and between C. Eric Winzer ("Executive") and Invitrogen Corporation, a Delaware Corporation ("Invitrogen" or the "Company")...Settlement and Retention Agreement • August 13th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
